This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
All clinical data and images are available and accessible on request.
Crump M, Neelapu SS, Farooq U, Van Den Neste E, Kuruvilla J, Westin J, et al. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood. 2017;130:1800–8. https://doi.org/10.1182/blood-2017-03-769620.
Cabanillas F, Shah B. Advances in diagnosis and management of diffuse large B-cell lymphoma. Clin Lymphoma Myeloma Leuk. 2017;17(12):783–96. https://doi.org/10.1016/j.clml.2017.10.007.
Neelapu SS, Locke FL, Bartlett NL, et al. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma. N Engl J Med. 2017;377:2531–44. https://doi.org/10.1056/NEJMoa1707447.
Rubin DB, Husain HD, Ali BA, Karen L, Sarah L, et al. Neurological toxicities associated with chimeric antigen receptor T-cell therapy. Brain. 2019;142(5):1334–48. https://doi.org/10.1093/brain/awz053.
Shah NN, Sarah JN, Drew AT, Michael DF, Wei-Ting H, Noelle F, et al. Early positron emission tomography/computed tomography as a predictor of response after CTL019 chimeric antigen receptor –T-cell therapy in B-cell non-hodgkin lymphomas. Cytotherapy. 2018;20(12):1415–8. https://doi.org/10.1016/j.jcyt.2018.10.003.
Ruff A, Hatcher JB, Austin RP, Esin CN, Mitchell EH, Sunita DN, et al. 18F-Fluorodeoxyglucose positron emission tomography/computed tomography following chimeric antigen receptor T-cell therapy in large b-cell lymphoma. Mol Imag Biol. 2021. https://doi.org/10.1007/s11307-021-01627-8.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Conflict of interest
The authors declare no competing interests.
Informed consent was obtained from the subject included in the study.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Image of the month.
About this article
Cite this article
Paccagnella, A., Farolfi, A., Casadei, B. et al. 2-[18F]FDG-PET/CT for early response and brain metabolic pattern assessment after CAR-T cell therapy in a diffuse large B cell lymphoma patient with ICANS. Eur J Nucl Med Mol Imaging (2021). https://doi.org/10.1007/s00259-021-05562-2